NCT05250557 Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
| NCT ID | NCT05250557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,429 participants |
| Start Date | 2021-08-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,429 participants in total. It began in 2021-08-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥20 years 2. All comers who underwent successful FFR measurement and pullback tracing Exclusion Criteria: 1. Chronic renal failure (estimated glomerular filtration rate \<30) 2. ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history 3. Primary myocardial or valvular disease 4. Left ventricular ejection fraction \< 30% 5. Hemodynamically unstable clinical conditions 6. Life expectancy \< 2 years
Contact & Investigator
Bon-Kwon Koo, MD, PhD
PRINCIPAL INVESTIGATOR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT05250557 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05250557 currently recruiting?
Yes, NCT05250557 is actively recruiting participants. Contact the research team at bkkoo@snu.ac.kr for enrollment information.
Where is the NCT05250557 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05250557 clinical trial?
NCT05250557 is sponsored by Seoul National University Hospital. The principal investigator is Bon-Kwon Koo, MD, PhD at Seoul National University Hospital. The trial plans to enroll 2,429 participants.